|
Annex
<br />Members of the WHO Study Group on Tobacco Product Regulation
<br />Erik Dybing, MD, PhD, Chair of the WHO Study Group on Tobacco Product
<br />Regulation, Director, Division of Environmental Medicine, Norwegian
<br />Institute of Public Health (NIPH), Oslo, Norway
<br />David L. Ashley, PhD, Chief, Emergency Response and Air Toxicants Branch,
<br />Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
<br />David Burns, MD, Professor of Family and Preventive Medicine, University of
<br />California, San Diego, School of Medicine, California, USA
<br />Mirjana Djordjevic, PhD, Program Director, National Cancer Institute,
<br />Division of Cancer Control and Population Sciences, Tobacco Control
<br />Research Branch, Bethesda, Maryland, USA
<br />Nigel Gray, MBBS, Scientist, International Agency for Research on Cancer,
<br />Lyon, France
<br />S. Katherine Hammond, PhD, Professor of Environmental Health Sciences,
<br />University of California, Berkeley, School of Public Health, Berkeley,
<br />California, USA
<br />Jack Henningfield, PhD, Vice President, Research and Health Policy, Pinney
<br />Associates, Bethesda, Maryland, USA
<br />Martin Jarvis, DSc, Principal Scientist, Cancer Research UK, Health
<br />Behaviour Unit, Royal Free and University College London Medical School,
<br />London, United Kingdom
<br />K. Srinath Reddy, MD, DM, Professor of Cardiology, All Institute of Medical
<br />Sciences, Delhi, India
<br />Charming Robertson, PhD, Senior Associate Dean for Faculty and Academic
<br />Affairs, School of Engineering, Stanford University, California, USA
<br />Ghazi Zaatari, MD, Professor and Chairman, Department of Pathology and
<br />Laboratory Medicine, American University of Beirut, Beirut, Lebanon
<br />io
<br />7rJ~-- _
<br />
|